Fifth Third Bancorp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.6M Buy
12,932
+6,175
+91% +$1.78M 0.01% 914
2025
Q4
$2.05M Sell
6,757
-931
-12% -$291K 0.01% 455
2025
Q3
$2.16M Sell
7,688
-377
-5% -$103K 0.01% 456
2025
Q2
$1.95M Sell
8,065
-206
-2% -$48.7K 0.01% 465
2025
Q1
$2.01M Sell
8,271
-1,154
-12% -$347K 0.01% 440
2024
Q4
$3.1M Sell
9,425
-2,993
-24% -$1.02M 0.01% 375
2024
Q3
$4.15M Sell
12,418
-177
-1% -$56.2K 0.02% 351
2024
Q2
$3.44M Buy
12,595
+1,368
+12% +$398K 0.01% 363
2024
Q1
$3.88M Buy
11,227
+1,718
+18% +$565K 0.02% 354
2023
Q4
$3.07M Sell
9,509
-3,793
-29% -$1.19M 0.01% 387
2023
Q3
$4.77M Buy
13,302
+949
+8% +$366K 0.02% 303
2023
Q2
$4.68M Buy
12,353
+1,424
+13% +$579K 0.02% 326
2023
Q1
$5.24M Buy
10,929
+571
+6% +$267K 0.02% 313
2022
Q4
$4.36M Buy
10,358
+953
+10% +$385K 0.02% 327
2022
Q3
$3.92M Buy
9,405
+2,232
+31% +$1.11M 0.02% 336
2022
Q2
$3.55M Buy
7,173
+244
+4% +$127K 0.02% 361
2022
Q1
$3.9M Buy
6,929
+728
+12% +$439K 0.02% 364
2021
Q4
$4.68M Sell
6,201
-152
-2% -$114K 0.02% 349
2021
Q3
$4.74M Buy
6,353
+1
+0% +$749 0.02% 349
2021
Q2
$4.09M Buy
6,352
+186
+3% +$113K 0.02% 362
2021
Q1
$3.52M Buy
6,166
+512
+9% +$303K 0.02% 378
2020
Q4
$3.3M Buy
5,654
+396
+8% +$226K 0.02% 374
2020
Q3
$2.71M Buy
5,258
+124
+2% +$62.8K 0.02% 379
2020
Q2
$2.32M Buy
5,134
+453
+10% +$200K 0.01% 389
2020
Q1
$1.64M Buy
4,681
+514
+12% +$189K 0.01% 404
2019
Q4
$1.54M Buy
4,167
+335
+9% +$118K 0.01% 457
2019
Q3
$1.27M Sell
3,832
-94
-2% -$30.7K 0.01% 480
2019
Q2
$1.23M Sell
3,926
-79
-2% -$23.7K 0.01% 465
2019
Q1
$1.22M Sell
4,005
-91
-2% -$24.6K 0.01% 452
2018
Q4
$951K Buy
4,096
+108
+3% +$29K 0.01% 483
2018
Q3
$1.25M Buy
3,988
+55
+1% +$17.1K 0.01% 470
2018
Q2
$1.14M Buy
3,933
+106
+3% +$29.3K 0.01% 491
2018
Q1
$957K Sell
3,827
-405
-10% -$103K 0.01% 511
2017
Q4
$1.01M Sell
4,232
-44
-1% -$10.7K 0.01% 506
2017
Q3
$950K Sell
4,276
-66
-2% -$14.9K 0.01% 520
2017
Q2
$983K Sell
4,342
-454
-9% -$98.9K 0.01% 536
2017
Q1
$956K Sell
4,796
-241
-5% -$46.4K 0.01% 549
2016
Q4
$918K Sell
5,037
-232
-4% -$39.6K 0.01% 559
2016
Q3
$863K Sell
5,269
-219
-4% -$33.2K 0.01% 570
2016
Q2
$785K Sell
5,488
-503
-8% -$71.7K 0.01% 589
2016
Q1
$819K Buy
5,991
+45
+0.8% +$5.91K 0.01% 572
2015
Q4
$824K Sell
5,946
-66
-1% -$9.15K 0.01% 583
2015
Q3
$807K Sell
6,012
-346
-5% -$49.8K 0.01% 597
2015
Q2
$958K Sell
6,358
-180
-3% -$25.8K 0.01% 585
2015
Q1
$884K Buy
6,538
+591
+10% +$73.3K 0.01% 610
2014
Q4
$717K Sell
5,947
-165
-3% -$19K 0.01% 642
2014
Q3
$693K Sell
6,112
-129
-2% -$15.3K 0.01% 652
2014
Q2
$747K Sell
6,241
-195
-3% -$23.8K 0.01% 630
2014
Q1
$825K Sell
6,436
-187
-3% -$24K 0.01% 610
2013
Q4
$819K Sell
6,623
-369
-5% -$45K 0.01% 635
2013
Q3
$822K Sell
6,992
-188
-3% -$22.2K 0.01% 623
2013
Q2
$806K Buy
+7,180
New +$842K 0.01% 632

Other funds holding BIO